Search Results - David Sebag-Montefiore
- Showing 1 - 12 results of 12
-
1
-
2
Evaluating the repeatability and set-up sensitivity of a large field of view distortion phantom and software for magnetic resonance-only radiotherapy by Jonathan Wyatt, Stephen Hedley, Emily Johnstone, Richard Speight, Charles Kelly, Ann Henry, Susan Short, Louise Murray, David Sebag-Montefiore, Hazel McCallum
Published in Physics and Imaging in Radiation Oncology (2018-04-01)Get full text
Article -
3
A phase 1 trial of the safety, tolerability and biological effects of intravenous Enadenotucirev, a novel oncolytic virus, in combination with chemoradiotherapy in locally advanced... by Séan M. O’Cathail, Steven Davis, Jane Holmes, Richard Brown, Kerry Fisher, Leonard Seymour, Richard Adams, James Good, David Sebag-Montefiore, Tim Maughan, Maria A. Hawkins
Published in Radiation Oncology (2020-06-01)Get full text
Article -
4
Mesorectal radiotherapy for early stage rectal cancer: A novel target volume by Femke P. Peters, Mark T.W. Teo, Ane L. Appelt, Simon Bach, Gunnar Baatrup, Johannes H.W. de Wilt, Camilla Jensenius Kronborg, Karen-Lise Garm Spindler, Corrie A.M. Marijnen, David Sebag-Montefiore
Published in Clinical and Translational Radiation Oncology (2020-03-01)Get full text
Article -
5
Patient position verification in magnetic-resonance imaging only radiotherapy of anal and rectal cancers by David Bird, Matthew Beasley, Michael G. Nix, Marcus Tyyger, Hazel McCallum, Mark Teo, Alexandra Gilbert, Nathalie Casanova, Rachel Cooper, David L. Buckley, David Sebag-Montefiore, Richard Speight, Ann M. Henry, Bashar Al-Qaisieh
Published in Physics and Imaging in Radiation Oncology (2021-07-01)Get full text
Article -
6
Brain Re-Irradiation Or Chemotherapy: a phase II randomised trial of re-irradiation and chemotherapy in patients with recurrent glioblastoma (BRIOChe) – protocol for a multi-centre... by Stuart Currie, Alexandra Smith, David Sebag-Montefiore, Helen Bulbeck, Jane Hughes, Susan Short, Eleanor M Hudson, Samantha Noutch, Catherine Parbutt, Louise Murray, Joanne Webster, Sarah R Brown, Florien W Boele, Omar Al-Salihi, Helen Baines, Sharon Fernandez, John Lilley, Finbar Slevin
Published in BMJ Open (2024-03-01)Get full text
Article -
7
Image-based consensus molecular subtyping in rectal cancer biopsies and response to neoadjuvant chemoradiotherapy by Maxime W. Lafarge, Enric Domingo, Korsuk Sirinukunwattana, Ruby Wood, Leslie Samuel, Graeme Murray, Susan D. Richman, Andrew Blake, David Sebag-Montefiore, Simon Gollins, Eckhard Klieser, Daniel Neureiter, Florian Huemer, Richard Greil, Philip Dunne, Philip Quirke, Lukas Weiss, Jens Rittscher, Tim Maughan, Viktor H. Koelzer
Published in npj Precision Oncology (2024-04-01)Get full text
Article -
8
Bayesian network structure for predicting local tumor recurrence in rectal cancer patients treated with neoadjuvant chemoradiation followed by surgery by Biche Osong, Carlotta Masciocchi, Andrea Damiani, Inigo Bermejo, Elisa Meldolesi, Giuditta Chiloiro, Maaike Berbee, Seok Ho Lee, Andre Dekker, Vincenzo Valentini, Jean-Pierre Gerard, Claus Rödel, Krzysztof Bujko, Cornelis van de Velde, Joakim Folkesson, Aldo Sainato, Robert Glynne-Jones, Samuel Ngan, Morten Brændengen, David Sebag-Montefiore, Johan van Soest
Published in Physics and Imaging in Radiation Oncology (2022-04-01)Get full text
Article -
9
A Phase II trial of Higher RadiOtherapy Dose In The Eradication of early rectal cancer (APHRODITE): protocol for a multicentre, open-label randomised controlled trial by Nicholas West, Sarah Brown, Alexandra Smith, Mark Saunders, Amanda Webster, David Sebag-Montefiore, Mark Teo, Simon Gollins, Jenny Seligmann, Simon P Bach, Monica Jefford, Alexandra Gilbert, Eleanor M Hudson, Samantha Noutch, Ravi Adapala, Carole Burnett, Alwyn Burrage, Maria Hawkins, Debra Howard, Rohit Kochhar, Edward JD Webb, Ane L Appelt
Published in BMJ Open (2022-04-01)Get full text
Article -
10
Identification and validation of a machine learning model of complete response to radiation in rectal cancer reveals immune infiltrate and TGFβ as key predictorsResearch in context... by Enric Domingo, Sanjay Rathee, Andrew Blake, Leslie Samuel, Graeme Murray, David Sebag-Montefiore, Simon Gollins, Nicholas West, Rubina Begum, Susan Richman, Phil Quirke, Keara Redmond, Aikaterini Chatzipli, Alessandro Barberis, Sylvana Hassanieh, Umair Mahmood, Michael Youdell, Ultan McDermott, Viktor Koelzer, Simon Leedham, Ian Tomlinson, Philip Dunne, Francesca M. Buffa, Timothy S. Maughan, Andrew Blake, Francesca Buffa, Enric Domingo, Geoffrey Higgins, Christopher Holmes, Viktor Koelzer, Simon Leedham, Timothy Maughan, Gillies McKenna, James Robineau, Ian Tomlinson, Michael Youdell, Philip Quirke, Susan Richman, David Sebag-Montefiore, Matthew Seymour, Nicholas West, Philip Dunne, Richard Kennedy, Mark Lawler, Keara Redmond, Manuel Salto-Tellez, Peter Campbell, Aikaterini Chatzipli, Claire Hardy, Ultan McDermott, Simon Bach, Andrew Beggs, Jean-Baptiste Cazier, Gary Middleton, Dion Morton, Celina Whalley, Louise Brown, Richard Kaplan, Graeme Murray, Richard Wilson, Richard Adams, Richard Sullivan, Leslie Samuel, Paul Harkin, Steven Walker, Jim Hill, Chieh-Hsi Wu, Dennis Horgan
Published in EBioMedicine (2024-08-01)Get full text
Article -
11
Practical guidance for running late-phase platform protocols for clinical trials: lessons from experienced UK clinical trials units by Sharon B. Love, Fay Cafferty, Claire Snowdon, Karen Carty, Joshua Savage, Philip Pallmann, Lucy McParland, Louise Brown, Lindsey Masters, Francesca Schiavone, Dominic Hague, Stephen Townsend, Claire Amos, Annabelle South, Kate Sturgeon, Ruth Langley, Timothy Maughan, Nicholas James, Emma Hall, Sarah Kernaghan, Judith Bliss, Nick Turner, Andrew Tutt, Christina Yap, Charlotte Firth, Anthony Kong, Hisham Mehanna, Colin Watts, Robert Hills, Ian Thomas, Mhairi Copland, Sue Bell, David Sebag-Montefiore, Robert Jones, Mahesh K. B. Parmar, Matthew R. Sydes
Published in Trials (2022-09-01)Get full text
Article -
12
International consensus to define outcomes for trials of chemoradiotherapy for anal cancer (CORMAC-2): defining the outcomes from the CORMAC core outcome set by Robert Samuel, Stephen R. Knight, Richard Adams, Prajnan Das, Jennifer Dorth, David Finch, Marianne G. Guren, Maria A. Hawkins, Susan Moug, Lakshmi Rajdev, David Sebag-Montefiore, Andrew G. Renehan, Rebecca Fish, Miguel A. Rodriguez-Bigas, Pratik Adusumilli, Ahmed Allam Mohamed, Mario Alvarez Gallego, Eva Angenete, Ane Appelt, Maaike Berbee, Danielle Brogden, Peter Brown, Lucy Buckley, Nathalie Casanova, Rachel Cooper, Nuno Couto, Peter Coyne, Tamzin Cuming, Charlotte Deijin, Kristopher Dennis, Cathy Eng, Alexandra Gilbert, Duncan Gilbert, Karyn Goodman, Rashmi Jadon, Anders Johnsson, Arunansu Kar, Ethan Ludmir, Marie-Louise Lydrup, Ivan Lyra-Gonzalez, Stefania Manfrida, Rebecca Muirhead, Sarah O'Dwyer, Thomas Rackley, Lukasz Raszewski, Leslie Samuel, Mark Saunders, Andrew Scarsbrook, Eva Segelov, Timothy Simmons, Paul Sutton, Nicholas Symons, Deborah Williamson
Published in EClinicalMedicine (2024-12-01)Get full text
Article
